サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1742557

アナフィラキシーの世界市場：産業分析、規模、シェア、成長、動向、予測、2025年～2035年

Anaphylaxis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日
ページ情報
英文 214 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
アナフィラキシーの世界市場：産業分析、規模、シェア、成長、動向、予測、2025年～2035年
出版日: 2025年04月26日
発行: Transparency Market Research
ページ情報: 英文 214 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アナフィラキシー市場 - 調査範囲

TMRの調査レポート「アナフィラキシーの世界市場」は、2025年から2035年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2025年を基準年、2035年を予測年として、2019年から2035年までの世界のアナフィラキシー市場の収益と予測を提供します。また、2025年から2035年までの世界のアナフィラキシー市場のCAGR（%）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、アナフィラキシー市場を推察しました。

市場スナップショット
2024年の市場規模 21億米ドル
2035年の市場規模 39億米ドル
CAGR 5.9%

本レポートでは、世界のアナフィラキシー市場の競合情勢について掘り下げています。世界のアナフィラキシー市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTが本レポートで紹介されている世界のアナフィラキシー市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー： 世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界のアナフィラキシー市場分析と予測、2020年～2035年

第5章 主要洞察

  • 主要地域/国における医療費支出
  • アナフィラキシー管理における技術の進歩
  • 主要地域/国における疫学
  • 主要地域/国における規制シナリオ
  • ポーターのファイブフォース分析
  • PESTEL分析
  • バリューチェーン分析
  • エンドユーザーにとっての主要な購入指標
  • 新規市場参入者のための市場開拓戦略
  • 主要な業界イベント（パートナーシップ、コラボレーション、製品承認、合併および買収）
  • 主要競合が提供する製品のベンチマーク

第6章 世界の市場分析と予測：薬剤クラス別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：薬剤クラス別、2020年～2035年
    • エピネフリン
    • 抗ヒスタミン薬
    • その他
  • 薬剤クラス別の市場の魅力

第7章 世界の市場分析と予測：剤形別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：剤形別、2020年～2035年
    • 注射剤
    • 錠剤/カプセル
    • その他
  • 剤形別の市場の魅力

第8章 世界の市場分析と予測：投与経路別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：投与経路別、2020年～2035年
    • 筋肉内注射
    • 皮下注射
    • 経口
    • その他
  • 投与経路別の市場の魅力

第9章 世界の市場分析と予測：薬剤タイプ別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：薬剤タイプ別、2020年～2035年
    • ブランド
    • ジェネリック
  • 薬剤タイプ別の市場の魅力

第10章 世界の市場分析と予測：流通チャネル別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：流通チャネル別、2020年～2035年
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • 流通チャネル別の市場の魅力

第11章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 地域別の市場の魅力

第12章 北米の市場分析と予測

  • 米国
  • カナダ

第13章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域

第14章 アジア太平洋地域の市場分析と予測

  • 中国
  • 日本
  • インド
  • オーストラリアとニュージーランド
  • その他アジア太平洋地域

第15章 ラテンアメリカ地域の市場分析と予測

  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域

第16章 中東・アフリカの市場分析と予測

  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

第17章 競合情勢

  • 市場企業 - 競合マトリックス（企業階層別・規模別）
  • 市場シェア分析：企業別（2024）
  • 企業プロファイル
    • Viatris Inc.
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Fresenius Kabi AG
    • Kaleo, Inc.
    • ARS Pharmaceuticals, Inc.
    • Mylan N.V.
    • Glenmark Pharmaceuticals
    • Bryn Pharma
    • Aquestive Therapeutics, Inc.
    • Endo, Inc.
    • DMK Pharmaceuticals Corporation
    • ALK-Abello A/S
    • Amneal Pharmaceuticals LLC
    • Grand Pharma（China）Co., Ltd.
図表

List of Tables

  • Table 01: Global Anaphylaxis Market Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • Table 02: Global Anaphylaxis Market Value (US$ Bn) Forecast, By Dosage Form, 2020-2035
  • Table 03: Global Anaphylaxis Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 04: Global Anaphylaxis Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  • Table 05: Global Anaphylaxis Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 06: Global Anaphylaxis Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 07: North America - Anaphylaxis Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 08: North America - Anaphylaxis Market Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • Table 09: North America - Anaphylaxis Market Value (US$ Bn) Forecast, By Dosage Form, 2020-2035
  • Table 10: North America - Anaphylaxis Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 11: North America - Anaphylaxis Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  • Table 12: North America - Anaphylaxis Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 13: Europe - Anaphylaxis Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 14: Europe - Anaphylaxis Market Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • Table 15: Europe - Anaphylaxis Market Value (US$ Bn) Forecast, By Dosage Form, 2020-2035
  • Table 16: Europe - Anaphylaxis Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 17: Europe - Anaphylaxis Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  • Table 18: Europe - Anaphylaxis Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 19: Asia Pacific - Anaphylaxis Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 20: Asia Pacific - Anaphylaxis Market Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • Table 21: Asia Pacific - Anaphylaxis Market Value (US$ Bn) Forecast, By Dosage Form, 2020-2035
  • Table 22: Asia Pacific - Anaphylaxis Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 23: Asia Pacific - Anaphylaxis Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  • Table 24: Asia Pacific - Anaphylaxis Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 25: Latin America - Anaphylaxis Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 26: Asia Pacific - Anaphylaxis Market Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • Table 27: Latin America - Anaphylaxis Market Value (US$ Bn) Forecast, By Dosage Form, 2020-2035
  • Table 28: Latin America - Anaphylaxis Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 29: Latin America - Anaphylaxis Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  • Table 30: Latin America - Anaphylaxis Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 31: Middle East & Africa - Anaphylaxis Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 32: Middle East & Africa - Anaphylaxis Market Value (US$ Bn) Forecast, By Drug Class, 2020-2035
  • Table 33: Middle East & Africa - Anaphylaxis Market Value (US$ Bn) Forecast, By Dosage Form, 2020-2035
  • Table 34: Middle East & Africa - Anaphylaxis Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 35: Middle East & Africa - Anaphylaxis Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  • Table 36: Middle East & Africa - Anaphylaxis Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035

List of Figures

  • Figure 01: Global Anaphylaxis Market Value Share Analysis, By Drug Class, 2024 and 2035
  • Figure 02: Global Anaphylaxis Market Attractiveness Analysis, By Drug Class, 2025-2035
  • Figure 03: Global Anaphylaxis Market Revenue (US$ Bn), by Epinephrine, 2020-2035
  • Figure 04: Global Anaphylaxis Market Revenue (US$ Bn), by Antihistamines, 2020-2035
  • Figure 05: Global Anaphylaxis Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 06: Global Anaphylaxis Market Value Share Analysis, By Dosage Form, 2024 and 2035
  • Figure 07: Global Anaphylaxis Market Attractiveness Analysis, By Dosage Form, 2025-2035
  • Figure 08: Global Anaphylaxis Market Revenue (US$ Bn), by Injectables, 2020-2035
  • Figure 09: Global Anaphylaxis Market Revenue (US$ Bn), by Tablets / Capsules, 2020-2035
  • Figure 10: Global Anaphylaxis Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 11: Global Anaphylaxis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 12: Global Anaphylaxis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 13: Global Anaphylaxis Market Revenue (US$ Bn), by Intramuscular Injection, 2020-2035
  • Figure 14: Global Anaphylaxis Market Revenue (US$ Bn), by Subcutaneous Injection, 2020-2035
  • Figure 15: Global Anaphylaxis Market Revenue (US$ Bn), by Oral, 2020-2035
  • Figure 16: Global Anaphylaxis Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 17: Global Anaphylaxis Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 18: Global Anaphylaxis Market Attractiveness Analysis, By Drug Type, 2025-2035
  • Figure 19: Global Anaphylaxis Market Revenue (US$ Bn), by Branded, 2020-2035
  • Figure 20: Global Anaphylaxis Market Revenue (US$ Bn), by Generic, 2020-2035
  • Figure 21: Global Anaphylaxis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 22: Global Anaphylaxis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 23: Global Anaphylaxis Market Revenue (US$ Bn), by Hospital Pharmacies, 2020-2035
  • Figure 24: Global Anaphylaxis Market Revenue (US$ Bn), by Retail Pharmacies, 2020-2035
  • Figure 25: Global Anaphylaxis Market Revenue (US$ Bn), by Online Pharmacies, 2020-2035
  • Figure 26: Global Anaphylaxis Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 27: Global Anaphylaxis Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 28: North America - Anaphylaxis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 29: North America - Anaphylaxis Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 30: North America - Anaphylaxis Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 31: North America - Anaphylaxis Market Value Share Analysis, By Drug Class, 2024 and 2035
  • Figure 32: North America - Anaphylaxis Market Attractiveness Analysis, By Drug Class, 2025-2035
  • Figure 33: North America - Anaphylaxis Market Value Share Analysis, By Dosage Form, 2024 and 2035
  • Figure 34: North America - Anaphylaxis Market Attractiveness Analysis, By Dosage Form, 2025-2035
  • Figure 35: North America - Anaphylaxis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 36: North America - Anaphylaxis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 37: North America - Anaphylaxis Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 38: North America - Anaphylaxis Market Attractiveness Analysis, By Drug Type, 2025-2035
  • Figure 39: North America - Anaphylaxis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 40: North America - Anaphylaxis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 41: Europe - Anaphylaxis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 42: Europe - Anaphylaxis Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 43: Europe - Anaphylaxis Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 44: Europe - Anaphylaxis Market Value Share Analysis, By Drug Class, 2024 and 2035
  • Figure 45: Europe - Anaphylaxis Market Attractiveness Analysis, By Drug Class, 2025-2035
  • Figure 46: Europe - Anaphylaxis Market Value Share Analysis, By Dosage Form, 2024 and 2035
  • Figure 47: Europe - Anaphylaxis Market Attractiveness Analysis, By Dosage Form, 2025-2035
  • Figure 48: Europe - Anaphylaxis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 49: Europe - Anaphylaxis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 50: Europe - Anaphylaxis Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 51: Europe - Anaphylaxis Market Attractiveness Analysis, By Drug Type, 2025-2035
  • Figure 52: Europe - Anaphylaxis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 53: Europe - Anaphylaxis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 54: Asia Pacific - Anaphylaxis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 55: Asia Pacific - Anaphylaxis Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 56: Asia Pacific - Anaphylaxis Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 57: Asia Pacific - Anaphylaxis Market Value Share Analysis, By Drug Class, 2024 and 2035
  • Figure 58: Asia Pacific - Anaphylaxis Market Attractiveness Analysis, By Drug Class, 2025-2035
  • Figure 59: Asia Pacific - Anaphylaxis Market Value Share Analysis, By Dosage Form, 2024 and 2035
  • Figure 60: Asia Pacific - Anaphylaxis Market Attractiveness Analysis, By Dosage Form, 2025-2035
  • Figure 61: Asia Pacific - Anaphylaxis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 62: Asia Pacific - Anaphylaxis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 63: Asia Pacific - Anaphylaxis Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 64: Asia Pacific - Anaphylaxis Market Attractiveness Analysis, By Drug Type, 2025-2035
  • Figure 65: Asia Pacific - Anaphylaxis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 66: Asia Pacific - Anaphylaxis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 67: Latin America - Anaphylaxis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 68: Latin America - Anaphylaxis Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 69: Latin America - Anaphylaxis Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 70: Latin America - Anaphylaxis Market Value Share Analysis, By Drug Class, 2024 and 2035
  • Figure 71: Latin America - Anaphylaxis Market Attractiveness Analysis, By Drug Class, 2025-2035
  • Figure 72: Latin America - Anaphylaxis Market Value Share Analysis, By Dosage Form, 2024 and 2035
  • Figure 73: Latin America - Anaphylaxis Market Attractiveness Analysis, By Dosage Form, 2025-2035
  • Figure 74: Latin America - Anaphylaxis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 75: Latin America - Anaphylaxis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 76: Latin America - Anaphylaxis Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 77: Latin America - Anaphylaxis Market Attractiveness Analysis, By Drug Type, 2025-2035
  • Figure 78: Latin America - Anaphylaxis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 79: Latin America - Anaphylaxis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 80: Middle East & Africa - Anaphylaxis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 81: Middle East & Africa - Anaphylaxis Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 82: Middle East & Africa - Anaphylaxis Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 83: Middle East & Africa - Anaphylaxis Market Value Share Analysis, By Drug Class, 2024 and 2035
  • Figure 84: Middle East & Africa - Anaphylaxis Market Attractiveness Analysis, By Drug Class, 2025-2035
  • Figure 85: Middle East & Africa - Anaphylaxis Market Value Share Analysis, By Dosage Form, 2024 and 2035
  • Figure 86: Middle East & Africa - Anaphylaxis Market Attractiveness Analysis, By Dosage Form, 2025-2035
  • Figure 87: Middle East & Africa - Anaphylaxis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 88: Middle East & Africa - Anaphylaxis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 89: Middle East & Africa - Anaphylaxis Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 90: Middle East & Africa - Anaphylaxis Market Attractiveness Analysis, By Drug Type, 2025-2035
  • Figure 91: Middle East & Africa - Anaphylaxis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 92: Middle East & Africa - Anaphylaxis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
目次
Product Code: TMRGL86653

Anaphylaxis Market - Scope of Report

TMR's report on the global anaphylaxis market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global anaphylaxis market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global anaphylaxis market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the anaphylaxis market.

Market Snapshot
Market Value in 2024US$ 2.1 Bn
Market Value in 2035US$ 3.9 Bn
CAGR5.9%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global anaphylaxis market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global anaphylaxis market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global anaphylaxis market.

The report delves into the competitive landscape of the global anaphylaxis market. Key players operating in the global anaphylaxis market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global anaphylaxis market profiled in this report.

Key Questions Answered in global anaphylaxis Market Report:

  • What is the sales/revenue generated by anaphylaxis across all regions during the forecast period?
  • What are the opportunities in the global anaphylaxis market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Anaphylaxis Market - Research Objectives and Research Approach

The comprehensive report on the global anaphylaxis market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global anaphylaxis market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global anaphylaxis market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Anaphylaxis Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Anaphylaxis Market Analysis and Forecasts, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Healthcare Expenditure across Key Regions / Countries
  • 5.2. Technological Advancements in Anaphylaxis Management
  • 5.3. Epidemiology of Anaphylaxis across Key Regions / Countries
  • 5.4. Regulatory Scenario across Key Regions / Countries
  • 5.5. PORTER's Five Forces Analysis
  • 5.6. PESTEL Analysis
  • 5.7. Value Chain Analysis
  • 5.8. Key Purchase Metrics for End-users
  • 5.9. Go-to-Market Strategy for New Market Entrants
  • 5.10. Key Industry Events (Partnerships, Collaborations, Product approvals, mergers & acquisitions)
  • 5.11. Benchmarking of Products Offered by the Leading Competitors

6. Global Anaphylaxis Market Analysis and Forecasts, By Drug Class

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Drug Class, 2020-2035
    • 6.3.1. Epinephrine
    • 6.3.2. Antihistamines
    • 6.3.3. Others
  • 6.4. Market Attractiveness By Drug Class

7. Global Anaphylaxis Market Analysis and Forecasts, By Dosage Form

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Dosage Form, 2020-2035
    • 7.3.1. Injectables
    • 7.3.2. Tablets / Capsules
    • 7.3.3. Others
  • 7.4. Market Attractiveness By Dosage Form

8. Global Anaphylaxis Market Analysis and Forecasts, By Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Route of Administration, 2020-2035
    • 8.3.1. Intramuscular Injection
    • 8.3.2. Subcutaneous Injection
    • 8.3.3. Oral
    • 8.3.4. Others
  • 8.4. Market Attractiveness By Route of Administration

9. Global Anaphylaxis Market Analysis and Forecasts, By Drug Type

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By Drug Type, 2020-2035
    • 9.3.1. Branded
    • 9.3.2. Generic
  • 9.4. Market Attractiveness By Drug Type

10. Global Anaphylaxis Market Analysis and Forecasts, By Distribution Channel

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast By Distribution Channel, 2020-2035
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Online Pharmacies
  • 10.4. Market Attractiveness By Distribution Channel

11. Global Anaphylaxis Market Analysis and Forecasts, By Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast By Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness By Region

12. North America Anaphylaxis Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Drug Class, 2020-2035
    • 12.2.1. Epinephrine
    • 12.2.2. Antihistamines
    • 12.2.3. Others
  • 12.3. Market Value Forecast By Dosage Form, 2020-2035
    • 12.3.1. Injectables
    • 12.3.2. Tablets / Capsules
    • 12.3.3. Others
  • 12.4. Market Value Forecast By Route of Administration, 2020-2035
    • 12.4.1. Intramuscular Injection
    • 12.4.2. Subcutaneous Injection
    • 12.4.3. Oral
    • 12.4.4. Others
  • 12.5. Market Value Forecast By Drug Type, 2020-2035
    • 12.5.1. Branded
    • 12.5.2. Generic
  • 12.6. Market Value Forecast By Distribution Channel, 2020-2035
    • 12.6.1. Hospital Pharmacies
    • 12.6.2. Retail Pharmacies
    • 12.6.3. Online Pharmacies
  • 12.7. Market Value Forecast By Country, 2020-2035
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Drug Class
    • 12.8.2. By Dosage Form
    • 12.8.3. By Route of Administration
    • 12.8.4. By Drug Type
    • 12.8.5. By Distribution Channel
    • 12.8.6. By Country

13. Europe Anaphylaxis Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Drug Class, 2020-2035
    • 13.2.1. Epinephrine
    • 13.2.2. Antihistamines
    • 13.2.3. Others
  • 13.3. Market Value Forecast By Dosage Form, 2020-2035
    • 13.3.1. Injectables
    • 13.3.2. Tablets / Capsules
    • 13.3.3. Others
  • 13.4. Market Value Forecast By Route of Administration, 2020-2035
    • 13.4.1. Intramuscular Injection
    • 13.4.2. Subcutaneous Injection
    • 13.4.3. Oral
    • 13.4.4. Others
  • 13.5. Market Value Forecast By Drug Type, 2020-2035
    • 13.5.1. Branded
    • 13.5.2. Generic
  • 13.6. Market Value Forecast By Distribution Channel, 2020-2035
    • 13.6.1. Hospital Pharmacies
    • 13.6.2. Retail Pharmacies
    • 13.6.3. Online Pharmacies
  • 13.7. Market Value Forecast By Country / Sub-region, 2020-2035
    • 13.7.1. Germany
    • 13.7.2. U.K.
    • 13.7.3. France
    • 13.7.4. Spain
    • 13.7.5. Italy
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Drug Class
    • 13.8.2. By Dosage Form
    • 13.8.3. By Route of Administration
    • 13.8.4. By Drug Type
    • 13.8.5. By Distribution Channel
    • 13.8.6. By Country / Sub-region

14. Asia Pacific Anaphylaxis Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Drug Class, 2020-2035
    • 14.2.1. Epinephrine
    • 14.2.2. Antihistamines
    • 14.2.3. Others
  • 14.3. Market Value Forecast By Dosage Form, 2020-2035
    • 14.3.1. Injectables
    • 14.3.2. Tablets / Capsules
    • 14.3.3. Others
  • 14.4. Market Value Forecast By Route of Administration, 2020-2035
    • 14.4.1. Intramuscular Injection
    • 14.4.2. Subcutaneous Injection
    • 14.4.3. Oral
    • 14.4.4. Others
  • 14.5. Market Value Forecast By Drug Type, 2020-2035
    • 14.5.1. Branded
    • 14.5.2. Generic
  • 14.6. Market Value Forecast By Distribution Channel, 2020-2035
    • 14.6.1. Hospital Pharmacies
    • 14.6.2. Retail Pharmacies
    • 14.6.3. Online Pharmacies
  • 14.7. Market Value Forecast By Country / Sub-region, 2020-2035
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Drug Class
    • 14.8.2. By Dosage Form
    • 14.8.3. By Route of Administration
    • 14.8.4. By Drug Type
    • 14.8.5. By Distribution Channel
    • 14.8.6. By Country / Sub-region

15. Latin America Anaphylaxis Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Drug Class, 2020-2035
    • 15.2.1. Epinephrine
    • 15.2.2. Antihistamines
    • 15.2.3. Others
  • 15.3. Market Value Forecast By Dosage Form, 2020-2035
    • 15.3.1. Injectables
    • 15.3.2. Tablets / Capsules
    • 15.3.3. Others
  • 15.4. Market Value Forecast By Route of Administration, 2020-2035
    • 15.4.1. Intramuscular Injection
    • 15.4.2. Subcutaneous Injection
    • 15.4.3. Oral
    • 15.4.4. Others
  • 15.5. Market Value Forecast By Drug Type, 2020-2035
    • 15.5.1. Branded
    • 15.5.2. Generic
  • 15.6. Market Value Forecast By Distribution Channel, 2020-2035
    • 15.6.1. Hospital Pharmacies
    • 15.6.2. Retail Pharmacies
    • 15.6.3. Online Pharmacies
  • 15.7. Market Value Forecast By Country / Sub-region, 2020-2035
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Drug Class
    • 15.8.2. By Dosage Form
    • 15.8.3. By Route of Administration
    • 15.8.4. By Drug Type
    • 15.8.5. By Distribution Channel
    • 15.8.6. By Country / Sub-region

16. Middle East & Africa Anaphylaxis Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast By Drug Class, 2020-2035
    • 16.2.1. Epinephrine
    • 16.2.2. Antihistamines
    • 16.2.3. Others
  • 16.3. Market Value Forecast By Dosage Form, 2020-2035
    • 16.3.1. Injectables
    • 16.3.2. Tablets / Capsules
    • 16.3.3. Others
  • 16.4. Market Value Forecast By Route of Administration, 2020-2035
    • 16.4.1. Intramuscular Injection
    • 16.4.2. Subcutaneous Injection
    • 16.4.3. Oral
    • 16.4.4. Others
  • 16.5. Market Value Forecast By Drug Type, 2020-2035
    • 16.5.1. Branded
    • 16.5.2. Generic
  • 16.6. Market Value Forecast By Distribution Channel, 2020-2035
    • 16.6.1. Hospital Pharmacies
    • 16.6.2. Retail Pharmacies
    • 16.6.3. Online Pharmacies
  • 16.7. Market Value Forecast By Country / Sub-region, 2020-2035
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Drug Class
    • 16.8.2. By Dosage Form
    • 16.8.3. By Route of Administration
    • 16.8.4. By Drug Type
    • 16.8.5. By Distribution Channel
    • 16.8.6. By Country / Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 17.2. Market Share Analysis By Company (2024)
  • 17.3. Company Profiles
    • 17.3.1. Viatris Inc.
      • 17.3.1.1. Company Overview
      • 17.3.1.2. Financial Overview
      • 17.3.1.3. Product Portfolio
      • 17.3.1.4. Business Strategies
      • 17.3.1.5. Recent Developments
    • 17.3.2. Pfizer Inc.
      • 17.3.2.1. Company Overview
      • 17.3.2.2. Financial Overview
      • 17.3.2.3. Product Portfolio
      • 17.3.2.4. Business Strategies
      • 17.3.2.5. Recent Developments
    • 17.3.3. Teva Pharmaceutical Industries Ltd.
      • 17.3.3.1. Company Overview
      • 17.3.3.2. Financial Overview
      • 17.3.3.3. Product Portfolio
      • 17.3.3.4. Business Strategies
      • 17.3.3.5. Recent Developments
    • 17.3.4. Fresenius Kabi AG
      • 17.3.4.1. Company Overview
      • 17.3.4.2. Financial Overview
      • 17.3.4.3. Product Portfolio
      • 17.3.4.4. Business Strategies
      • 17.3.4.5. Recent Developments
    • 17.3.5. Kaleo, Inc.
      • 17.3.5.1. Company Overview
      • 17.3.5.2. Financial Overview
      • 17.3.5.3. Product Portfolio
      • 17.3.5.4. Business Strategies
      • 17.3.5.5. Recent Developments
    • 17.3.6. ARS Pharmaceuticals, Inc.
      • 17.3.6.1. Company Overview
      • 17.3.6.2. Financial Overview
      • 17.3.6.3. Product Portfolio
      • 17.3.6.4. Business Strategies
      • 17.3.6.5. Recent Developments
    • 17.3.7. Mylan N.V.
      • 17.3.7.1. Company Overview
      • 17.3.7.2. Financial Overview
      • 17.3.7.3. Product Portfolio
      • 17.3.7.4. Business Strategies
      • 17.3.7.5. Recent Developments
    • 17.3.8. Glenmark Pharmaceuticals
      • 17.3.8.1. Company Overview
      • 17.3.8.2. Financial Overview
      • 17.3.8.3. Product Portfolio
      • 17.3.8.4. Business Strategies
      • 17.3.8.5. Recent Developments
    • 17.3.9. Bryn Pharma
      • 17.3.9.1. Company Overview
      • 17.3.9.2. Financial Overview
      • 17.3.9.3. Product Portfolio
      • 17.3.9.4. Business Strategies
      • 17.3.9.5. Recent Developments
    • 17.3.10. Aquestive Therapeutics, Inc.
      • 17.3.10.1. Company Overview
      • 17.3.10.2. Financial Overview
      • 17.3.10.3. Product Portfolio
      • 17.3.10.4. Business Strategies
      • 17.3.10.5. Recent Developments
    • 17.3.11. Endo, Inc.
      • 17.3.11.1. Company Overview
      • 17.3.11.2. Financial Overview
      • 17.3.11.3. Product Portfolio
      • 17.3.11.4. Business Strategies
      • 17.3.11.5. Recent Developments
    • 17.3.12. DMK Pharmaceuticals Corporation
      • 17.3.12.1. Company Overview
      • 17.3.12.2. Financial Overview
      • 17.3.12.3. Product Portfolio
      • 17.3.12.4. Business Strategies
      • 17.3.12.5. Recent Developments
    • 17.3.13. ALK-Abello A/S
      • 17.3.13.1. Company Overview
      • 17.3.13.2. Financial Overview
      • 17.3.13.3. Product Portfolio
      • 17.3.13.4. Business Strategies
      • 17.3.13.5. Recent Developments
    • 17.3.14. Amneal Pharmaceuticals LLC
      • 17.3.14.1. Company Overview
      • 17.3.14.2. Financial Overview
      • 17.3.14.3. Product Portfolio
      • 17.3.14.4. Business Strategies
      • 17.3.14.5. Recent Developments
    • 17.3.15. Grand Pharma (China) Co., Ltd.
      • 17.3.15.1. Company Overview
      • 17.3.15.2. Financial Overview
      • 17.3.15.3. Product Portfolio
      • 17.3.15.4. Business Strategies
      • 17.3.15.5. Recent Developments